Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

450.50
+6.681.51%
Pre-market: 443.77-6.7300-1.49%04:00 EDT
Volume:960.50K
Turnover:431.61M
Market Cap:115.69B
PE:-117.27
High:451.66
Open:443.83
Low:443.83
Close:443.82
Loading ...

Vertex Pharmaceuticals Inc : JP Morgan Raises Target Price to $515 From $512

THOMSON REUTERS
·
06 May

Vertex Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Vertex Pharmaceuticals (VRTX) Misses Q1 Earnings and Revenue Estimates

Zacks
·
06 May

Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance

Benzinga
·
06 May

Vertex Pharmaceuticals 1Q Sales Rise, Profit Falls on Impairment Charge

Dow Jones
·
06 May

Vertex Pharmaceuticals Q1 Non-GAAP Earnings Fall, Revenue Increase; Adjusts 2025 Guidance

MT Newswires Live
·
06 May

Vertex: Q1 Earnings Snapshot

Associated Press Finance
·
06 May

Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug

Reuters
·
06 May

Shares of Vertex Pharma Down 3% in Extended Trade After Quarterly Report

THOMSON REUTERS
·
06 May

BRIEF-Vertex Pharmaceuticals Posts Q1 Adjusted EPS Of $4.06

Reuters
·
06 May

Vertex Pharmaceuticals: Intangible Asset Impairment Charge of $379.0 Mln Associated With Vx-264 in Q1

THOMSON REUTERS
·
06 May

Vertex Pharmaceuticals Q1 Adj EPS $4.06 VS Ibes Estimate $4.32

THOMSON REUTERS
·
06 May

Vertex Pharmaceuticals: 2025 Guidance Includes an Immaterial Cost Impact From Tariffs

THOMSON REUTERS
·
06 May

Vertex Pharmaceuticals Q1 Adj. EPS $4.06 Misses $4.32 Estimate, Sales $2.77B Miss $2.85B Estimate

Benzinga
·
06 May

CORRECTED-BRIEF-Vertex Pharmaceuticals Q1 Revenue USD 2,770 Million Vs. IBES Estimate USD 2,853 Million

Reuters
·
06 May

Corrected-Vertex Pharmaceuticals Q1 Adjusted Operating Income USD 1,183 Million VS. Ibes Estimate USD 1,254 Million (Corrects Amount)

THOMSON REUTERS
·
06 May

Corrected- Vertex Pharmaceuticals Outlook FY Total Revenue USD 11,850-12,000 Million (Not 'Product Revenue', Corrects Amount)

THOMSON REUTERS
·
06 May

Vertex Pharmaceuticals Outlook FY Product Revenue USD 11,750-12,000 Million

THOMSON REUTERS
·
06 May

Vertex Pharmaceuticals Q1 Revenue USD 2,760.2 Million VS. Ibes Estimate USD 2,853 Million

THOMSON REUTERS
·
06 May

Vertex Reports First Quarter 2025 Financial Results

Business Wire
·
06 May